Novem Group Has $1.71 Million Stake in Procter & Gamble Company (The) $PG

Key Points

• Novem Group increased its stake in Procter & Gamble Company by 65.8%, now owning 10,744 shares valued at $1.71 million as of their latest SEC filing.
• Several institutional investors have also adjusted their positions, with Brighton Jones LLC growing its stake by 51.5% in the fourth quarter, raising its ownership to 40,068 shares worth approximately $6.72 million.
• Analyst recommendations vary, with UBS Group setting a price objective of $180, while Wells Fargo & Company reduced their target to $170, indicating a moderate outlook for the stock.

Novem Group increased its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 65.8% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,744 shares of the company's stock after acquiring an additional 4,265 shares during the period. Novem Group's holdings in Procter & Gamble were worth $1,712,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Brighton Jones LLC grew its position in Procter & Gamble by 51.5% in the fourth quarter. Brighton Jones LLC now owns 40,068 shares of the company's stock valued at $6,717,000 after purchasing an additional 13,617 shares in the last quarter. Two Sigma Investments LP grew its position in Procter & Gamble by 2.4% in the fourth quarter. Two Sigma Investments LP now owns 18,133 shares of the company's stock valued at $3,040,000 after purchasing an additional 433 shares in the last quarter. Copia Wealth Management bought a new position in Procter & Gamble in the fourth quarter valued at $68,000. Centaurus Financial Inc. grew its position in shares of Procter & Gamble by 1.1% in the 4th quarter. Centaurus Financial Inc. now owns 10,799 shares of the company's stock valued at $1,811,000 after acquiring an additional 122 shares during the period. Finally, 111 Capital bought a new position in shares of Procter & Gamble in the 4th quarter valued at about $716,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. UBS Group set a $180.00 price objective on shares of Procter & Gamble and gave the company a "buy" rating in a research report on Wednesday, July 30th. Barclays set a $164.00 target price on shares of Procter & Gamble and gave the stock an "equal weight" rating in a report on Thursday, July 31st. Evercore ISI reaffirmed an "in-line" rating and set a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Wells Fargo & Company reduced their target price on shares of Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating for the company in a report on Thursday. Finally, Berenberg Bank lifted their target price on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a "hold" rating in a report on Wednesday, September 17th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat, Procter & Gamble currently has an average rating of "Moderate Buy" and an average target price of $173.78.

Procter & Gamble Stock Performance

NYSE PG opened at $152.18 on Friday. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. The company has a market capitalization of $356.17 billion, a P/E ratio of 23.38, a P/E/G ratio of 4.02 and a beta of 0.36. Procter & Gamble Company has a 12-month low of $149.91 and a 12-month high of $180.43. The firm has a 50-day moving average price of $156.05 and a two-hundred day moving average price of $160.74.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. The firm had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business's revenue for the quarter was up 1.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were given a $1.0568 dividend. The ex-dividend date was Friday, July 18th. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. Procter & Gamble's payout ratio is presently 64.98%.

Insider Buying and Selling

In other news, CFO Andre Schulten sold 11,638 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,830,308.26. Following the completion of the transaction, the chief financial officer directly owned 52,642 shares in the company, valued at approximately $8,279,007.34. The trade was a 18.11% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Gary A. Coombe sold 10,194 shares of the business's stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the completion of the transaction, the chief executive officer owned 34,978 shares of the company's stock, valued at $5,532,120.48. The trade was a 22.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 120,181 shares of company stock worth $18,918,012. 0.20% of the stock is owned by company insiders.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.